October 2021
The most impactful paper related to movement disorders therapy in the 20th century
Dr. Schaefer speaks with Dr. Stanley Fahn about the origins of levodopa therapy for Parkinson's disease in the 1960s, how that generated an explosion of interest and research in dopamine's role in movement disorders and beyond, and how it all led to the dawning of the movement disorders field, journal, society, and community that we are all part of today. Read the article.
Listen now »
October 2021 - Special Issue
Swim for Parkinson: Swimming together to improve together
The neurologists Dr. Francesca Morgante and Dr. Nicola Modugno and Cecilia Ferrari, a person with Parkinson's disease, share their experience swimming across the strait of Messina, highlighting the importance of physical activity in PD.
Listen now »
October 2021 - 2021 Review Article Award from the Movement Disorders Journal
Variability of movement disorders: The influence of sensation, action, cognition, and emotions
Dr. Matarazzo speaks with Prof. Maja Kojović about the paper awarded as 2021 best review article from the Movement Disorders Journal, highlighting the impact on several factors on the variability of movement disorders. Read the article.
Listen now »
July 2021
Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target?
Dr. Matarazzo speaks with Prof. Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression. Read the article.
Listen now »
September 2021 - MDS Congress 2021 Special Issue
An interview with Claudia Trenkwalder, MDS President
Dr. Schaefer discusses with Dr. Trenkwalder the 2021 Virtual MDS Congress, her tenure as the MDS president, and her hopes for the future of the MDS.
Listen now »
September 2021 - 2021 Research Article Award from the Movement Disorders Journal
Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson's disease patients
Dr. Schaefer speaks with Dr. Kanthasamy about RT-QuIC from skin tissues as a potential new biomarker for Parkinson's disease. Read the article
Listen now »
August 2021
TikTok Tics
Dr. Schaefer speaks with Dr. Olvera about trending videos of tics and other neurological syndromes on social media. Read the article.
Listen now »
June 2021
Cognitive and visuospatial abilities in dystonia
Dr. Schaefer speaks with Dr. Camargo about the non-motor and prodromal features of dystonia. Read the article.
Listen now »
May 2021
Autophagy in Levodopa-Induced Dyskinesia. A new potential therapeutic target?
Dr. Matarazzo interviews Prof. Fisone about the role of autophagy in Levodopa-Induced Dyskinesia. Read the article.
Listen now »
April 2021
Electroconvulsive therapy in movement disorders
Dr. Schaefer discusses with Dr. Garcia Ruiz his recent paper in Movement Disorders Clinical Practice discussing the history and data behind the use of electroconvulsive therapy in Parkinson's disease and other movement disorders. Read the article.
Listen now »
March 2021
Acetylcholine Nuclei Atrophy Predicts Gait Changes in Parkinson's Disease
Dr. Matarazzo interviews Dr. Ray on a recently published article that demonstrates a relationship between changes in cholinergic nuclei in MRI and future gait disorders in Parkinson's disease. Read the article.
Listen now »
February 2021
Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough?
Dr. Schaefer speaks with Dr. Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions.Read the article.
Listen now »
February 2021
Anxiety in Parkinson's disease and its correlates in MRI-based functional connectivity
Dr. Matarazzo interviews Dr. De Micco on the functional MRI correlates of anxiety in Parkinson's disease, highlighting the main results of the article she recently published on the topic in the Movement Disorders Journal. Read the article.
Listen now »
January 2021
Dr. Wu discusses a newly-described peripherally-induced movement disorder (PIMD), and discusses with Dr. Schaefer the potential pathophysiologies of PIMDs. Read the article.
Listen now »
January 2021
Neuroinflammation in Parkinson's Disease, where are we now?
Dr. Matarazzo interviews Dr. Standaert about the review article he recently published on neuroinflammation in Parkinson's disease, including the main evidence of its role on the pathogenesis of the disease and how understanding it better may help us discovering new therapeutic targets. Read the article.
Listen now »
Episode Archive
Dr. Brit Mollenhauer discusses the recent advances in the use of neurofilament light chain for the diagnosis and follow up of Parkinson's disease and related disorders, highlighting the results of a recent longitudinal study. Read the article.
Click to listen now
Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort. Read the article.
Click to listen now
In this interview, Prof. Brit Mollenhauer provides insight into how researchers have been coping with the COVID-19 pandemic. Read the article.
Click to listen now
Dr. Michele Matarazzo interviews Dr. Amy Amara, the first author of the article awarded as "2020 Research Article from Movement Disorders" on the effects of exercise on sleep in Parkinson's disease. Read the article.
Click to listen now
Dr. Michele Matarazzo interviews Dr. Kazuto Tsukita, the first author of the article awarded as "2020 Review Article from Movement Disorders" on the advances of in-vivo alpha-synuclein detection as a biomarker for Parkinson. Read the article.
Click to listen now
In this interview, Prof. Deuschl highlights the main results of the EARLYSTIM project, focusing on non-motor outcomes, and especially on the effects of DBS on Social and Occupational Functioning in Parkinson's Disease. Read the article.
Click to listen now
Preprint articles of scientific results have been thrust into the spotlight due to the desire for rapid results pertaining to COVID-19. Here, we dive into the trend with Movement Disorders’ editor, Dr. Jon Stoessl. Read the article.
Click to listen now
Dr. Matarazzo interviews Dr. Anette Schrag about the recently published article on late-stage parkinsonism and related neuropsychiatric complications. Why is it important? And are we doing enough to help patients at this stage? Read the article.
Click to listen now
In this interview the president of the MDS, Prof Claudia Trenkwalder shares the main changes and strategies that the MDS is implementing to adapt to the COVID-19 pandemic, including the replacement of the International MDS congress with a virtual meeting.
Click to listen now
Dr. Matarazzo interviews Prof. Roy Alcalay on the effects that the COVID-19 pandemic is having on the clinical activity and how it is changing the way we see patients. Will telemedicine be an integrating part of our clinical practice?
Click to listen now
Dr. Matarazzo interviews Prof. Angelo Antonini on the effect of the COVID-19 pandemic on Parkinson's disease and other movement disorders patients and how to manage them. And also, what is the evidence of a link between COVID-19 and Parkinson's disease? Read the article.
Click to listen now
In this issue Dr. Sheperjans shares the results of the article published in the March 2020 issue of the Movement Disorders Journal on the effect of antibiotic exposure on the risk of developing Parkinson's disease. Read the article.
Click to listen now
Dr. Schaefer discusses with Dr. Lidstone her recent paper in Movement Disorders Clinical Practice about a novel, multidisciplinary therapeutic intervention for functional movement disorders patients. Read the article.
Click to listen now
Dr. Dayal discusses with Dr. Matarazzo how adjusting the pulse width of deep brain stimulation could impact Parkinson's disease, highlighting the results of the paper he recently published in the Movement Disorder Journal. Read the article.
Click to listen now
Dr. Schaefer discusses with Dr. Gregory her recent study on neuroimaging changes and fluid biomarkers in Huntington's disease, and how those may be used to better characterize the biological basis for neurodegeneration in this disease. Read the article.
Click to listen now
Listen to the October 2019 Special Issues from the 2019 MDS Congress
As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Chaudhuri about news in Parkinson’s disease and Lewy body dementia, including new treatments, scales and other advances in early and late-stage PD.
Click to listen now
As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Espay about technology in movement disorders, highlighting recent advances and the goal of the MDS to create a platform that will combine technology-based data and e-diaries.
Click to listen now
As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Elble about recent advances in tremor classification, diagnosis and treatment approaches, and about the future plans of the MDS Tremor study group to overcome current challenges for clinicians and researchers.
Click to listen now
As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Ganos about the newly created MDS Tic Disorders and Tourette Syndrome Study Group, and the main news breakthroughs in the field, that have been discussed during the MDS Congress.
Click to listen now
As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Respondek about atypical parkinsonisms, focusing on the MDS activities to advance in the knowledge and management of these diseases and facilitate clinical trials.
Click to listen now
Dr. Schaefer discusses with Dr. Kamel the role of botulinum toxin in the treatment of refractory upper limb tremor, and his center's tailored approach to provide relief for these patients. Read the article.
Click to listen now
As part of the MDS Congress 2019 Special Issue, Dr. Schaefer interviews Dr. Strafella about the emerging research in neuroimaging in movement disorders and plans to establish a centralized database for neuroimaging in atypical parkinsonisms.
Click to listen now
As part of the MDS Congress 2019 Special Issue, Dr. Schaefer interviews Dr. Jinnah about notable research in dystonia and activities of the MDS Dystonia Study Group.
Click to listen now
As part of the MDS Congress 2019 Special Issue, Dr. Schaefer and Dr. Tabrizi discuss the evolving research in disease-modifying therapies for Huntington's Disease, and what may come next.
Click to listen now
Did you miss the MDS Congress in Nice, or do you just want an overview of highlights from the International Congress as well as a look forward at new ventures? Dr. Schaefer introduces the MDS Congress 2019 special issue, which features interviews with experts in various fields of movement disorders at the MDS Congress 2019. In this first issue, Dr. Schaefer interviews Dr. LaFaver about notable research in functional movement disorders, activities of the MDS Functional Movement Disorders Study Group, and more.
Click to listen now
As part of the MDS Congress 2019 Special Issue, Dr. Schaefer interviews Dr. Postuma about all of the educational offerings through the MDS, as well as new projects of the MDS Education Committee.
Click to listen now